Editorial to the Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF Japan): One‐year safety and effectiveness analyses
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-06-01
|
| Series: | Journal of Arrhythmia |
| Online Access: | https://doi.org/10.1002/joa3.12340 |
| _version_ | 1818656186079117312 |
|---|---|
| author | Koichi Nagashima Yasuo Okumura |
| author_facet | Koichi Nagashima Yasuo Okumura |
| author_sort | Koichi Nagashima |
| collection | DOAJ |
| first_indexed | 2024-12-17T03:21:35Z |
| format | Article |
| id | doaj.art-e4bc725212594a8b94d7b5b3bfe30807 |
| institution | Directory Open Access Journal |
| issn | 1880-4276 1883-2148 |
| language | English |
| last_indexed | 2024-12-17T03:21:35Z |
| publishDate | 2020-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Arrhythmia |
| spelling | doaj.art-e4bc725212594a8b94d7b5b3bfe308072022-12-21T22:05:31ZengWileyJournal of Arrhythmia1880-42761883-21482020-06-0136340640710.1002/joa3.12340Editorial to the Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF Japan): One‐year safety and effectiveness analysesKoichi Nagashima0Yasuo Okumura1Division of Cardiology Department of Medicine Nihon University School of Medicine Tokyo JapanDivision of Cardiology Department of Medicine Nihon University School of Medicine Tokyo Japanhttps://doi.org/10.1002/joa3.12340 |
| spellingShingle | Koichi Nagashima Yasuo Okumura Editorial to the Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF Japan): One‐year safety and effectiveness analyses Journal of Arrhythmia |
| title | Editorial to the Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF Japan): One‐year safety and effectiveness analyses |
| title_full | Editorial to the Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF Japan): One‐year safety and effectiveness analyses |
| title_fullStr | Editorial to the Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF Japan): One‐year safety and effectiveness analyses |
| title_full_unstemmed | Editorial to the Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF Japan): One‐year safety and effectiveness analyses |
| title_short | Editorial to the Postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation (ETNA‐AF Japan): One‐year safety and effectiveness analyses |
| title_sort | editorial to the postmarketing surveillance on the clinical use of edoxaban in patients with nonvalvular atrial fibrillation etna af japan one year safety and effectiveness analyses |
| url | https://doi.org/10.1002/joa3.12340 |
| work_keys_str_mv | AT koichinagashima editorialtothepostmarketingsurveillanceontheclinicaluseofedoxabaninpatientswithnonvalvularatrialfibrillationetnaafjapanoneyearsafetyandeffectivenessanalyses AT yasuookumura editorialtothepostmarketingsurveillanceontheclinicaluseofedoxabaninpatientswithnonvalvularatrialfibrillationetnaafjapanoneyearsafetyandeffectivenessanalyses |